Breast and Cervical Cancer Press Releases
The following is a statement from American Cancer Society Cancer Action Network (ACS CAN) New York Senior Government Relations Director Michael Davoli:
“Coming off Governor Hochul’s State of the State address earlier this week, where access to and the costs of health care were sparingly mentioned, patient advocates are hopeful that the governor prioritizes health care affordability in her executive budget proposal for FY 2025-26.
TALLAHASSEE, Florida – As Florida legislators begin committee meetings for the 2025 session, the American Cancer Society Cancer Action Network (ACS CAN) calls on them to prioritize reducing the cancer burden on Floridians.
As Governor Daniel McKee prepares for his State of the State address, patient advocates are highlighting the results of a new report by the American Cancer Society Cancer Action Network (ACS CAN), which found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
BISMARCK, N.D. -- As North Dakota legislators close their first week of business for the new year, American Cancer Society Cancer Action Network advocates on Monday will ask them to take strong action to reduce the cost of fighting cancer.
As the Colorado General Assembly convenes for its 75th regular session on Wednesday, the American Cancer Society Cancer Action Network (ACS CAN) and its team of advocates is calling on legislators to support several priorities to improve the prevention, early detection and treatment of cancer.
Legislation will eliminate costly barriers to follow up breast cancer screening
S.2971, An Act relative to medically necessary breast screenings and exams for equity and early detection requires that health plans regulated by the Commonwealth cover medically necessary screening and diagnostic breast imaging with no out- of-pocket costs.
